| Identification | Back Directory | [Name]
Thieno[2,3-b]pyridine-2-carboxamide, 3-amino-N-[(2S)-6-(3,8-diazabicyclo[3.2.1]oct-3-yl)-1,2,3,4-tetrahydro-2-naphthalenyl]-6-methyl- | [CAS]
2278274-34-1 | [Synonyms]
FT206
Thieno[2,3-b]pyridine-2-carboxamide, 3-amino-N-[(2S)-6-(3,8-diazabicyclo[3.2.1]oct-3-yl)-1,2,3,4-tetrahydro-2-naphthalenyl]-6-methyl- | [Molecular Formula]
C25H29N5OS | [MDL Number]
MFCD34473229 | [MOL File]
2278274-34-1.mol | [Molecular Weight]
447.6 |
| Chemical Properties | Back Directory | [Boiling point ]
742.5±60.0 °C(Predicted) | [density ]
1.36±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 150 mg/mL (335.12 mM; Need ultrasonic) | [form ]
Solid | [pka]
13.20±0.20(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Biological Activity]
FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1[1]. | [References]
[1]. WO2020033707 |
|
|